Literature DB >> 21076190

Dose perturbations and image artifacts caused by carbon-coated ceramic and stainless steel fiducials used in proton therapy for prostate cancer.

Joey Cheung1, Rajat J Kudchadker, X Ronald Zhu, Andrew K Lee, Wayne D Newhauser.   

Abstract

Image-guided radiation therapy using implanted fiducial markers is a common solution for prostate localization to improve targeting accuracy. However, fiducials that are typically used for conventional photon radiotherapy cause large dose perturbations in patients who receive proton radiotherapy. A proposed solution has been to use fiducials of lower atomic number (Z) materials to minimize this effect in tissue, but the effects of these fiducials on dose distributions have not been quantified. The objective of this study was to analyze the magnitude of the dose perturbations caused by select lower-Z fiducials (a carbon-coated zirconium dioxide fiducial and a plastic-coated stainless steel fiducial) and compare them to perturbations caused by conventional gold fiducials. Sets of phantoms were used to assess select components of the effects on dose. First, the fiducials were assessed for radiographic visibility using both conventional computed tomography (CT) and an on-board kilovoltage imaging device at our proton therapy center. CT streak artifacts from the fiducials were also measured in a separate phantom. Second, dose perturbations were measured downstream of the fiducials using radiochromic film. The magnitude of dose perturbation was characterized as a function of marker material, implantation depth and orientation with respect to the beam axis. The radiographic visibility of the markers was deemed to be acceptable for clinical use. The dose measurements showed that the perpendicularly oriented zirconium dioxide and stainless steel fiducials located near the center of modulation of the proton beam perturbed the dose by less than 10%, but that the same fiducials in a parallel orientation near the end of the range of the beam could perturb the dose by as much as 38%. This suggests that carbon-coated and stainless steel fiducials could be used in proton therapy if they are located far from the end of the range of the beam and if they are oriented perpendicular to the beam axis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21076190     DOI: 10.1088/0031-9155/55/23/S13

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  14 in total

Review 1.  Charged-particle therapy for hepatocellular carcinoma.

Authors:  Heath D Skinner; Theodore S Hong; Sunil Krishnan
Journal:  Semin Radiat Oncol       Date:  2011-10       Impact factor: 5.934

2.  Qualitative evaluation of fiducial markers for radiotherapy imaging.

Authors:  Maria F Chan; Gil'ad N Cohen; Joseph O Deasy
Journal:  Technol Cancer Res Treat       Date:  2014-09-16

3.  Investigation of dose perturbations and the radiographic visibility of potential fiducials for proton radiation therapy of the prostate.

Authors:  Jessie Y Huang; Wayne D Newhauser; X Ronald Zhu; Andrew K Lee; Rajat J Kudchadker
Journal:  Phys Med Biol       Date:  2011-07-28       Impact factor: 3.609

Review 4.  The physics of proton therapy.

Authors:  Wayne D Newhauser; Rui Zhang
Journal:  Phys Med Biol       Date:  2015-03-24       Impact factor: 3.609

5.  Feasibility of proton-activated implantable markers for proton range verification using PET.

Authors:  Jongmin Cho; Geoffrey Ibbott; Michael Gillin; Carlos Gonzalez-Lepera; Uwe Titt; Harald Paganetti; Matthew Kerr; Osama Mawlawi
Journal:  Phys Med Biol       Date:  2013-10-08       Impact factor: 3.609

6.  A new scheme for real-time high-contrast imaging in lung cancer radiotherapy: a proof-of-concept study.

Authors:  Hao Yan; Zhen Tian; Yiping Shao; Steve B Jiang; Xun Jia
Journal:  Phys Med Biol       Date:  2016-03-04       Impact factor: 3.609

7.  Dosimetric evaluation of MR-derived synthetic-CTs for MR-only proton treatment planning.

Authors:  David Aramburu Núñez; Sandra Fontenla; Lauren Rydquist; Gabriely Del Rosario; Zhiqiang Han; Chin-Cheng Chen; Dennis Mah; Neelam Tyagi
Journal:  Med Dosim       Date:  2020-02-20       Impact factor: 1.482

8.  Evaluation of different fiducial markers for image-guided radiotherapy and particle therapy.

Authors:  Daniel Habermehl; Katrin Henkner; Swantje Ecker; Oliver Jäkel; Jürgen Debus; Stephanie E Combs
Journal:  J Radiat Res       Date:  2013-07       Impact factor: 2.724

9.  A semi-empirical model for the therapeutic range shift estimation caused by inhomogeneities in proton beam therapy.

Authors:  Vadim Moskvin; Chee-Wai Cheng; Leia Fanelli; Li Zhao; Indra J Das
Journal:  J Appl Clin Med Phys       Date:  2012-03-08       Impact factor: 2.102

10.  Depth dose perturbation by a hydrogel fiducial marker in a proton beam.

Authors:  Miao Zhang; Meral Reyhan; Leonard H Kim
Journal:  J Appl Clin Med Phys       Date:  2015-01-08       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.